Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.8 (
cholinesterase
)
12,691
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. The toxic gas hypothesis proposes exposure to stibine (antimony trihydride) generated from microbial contamination of
cot
mattress materials as a possible cause of unexplained death in infancy (SIDS) as a consequence of
cholinesterase
inhibition. We have measured the direct effects of antimony compounds including stibine on the activity of plasma
cholinesterase
, red blood cell acetylcholinesterase (AChE) and mouse neuronal AChE in vitro. 2. Colorimetric assays for the different esterases with potassium antimonyl tartrate or antimony trichloride at concentrations up to 10(-3) M in the presence of substrate concentrations sufficient to produce 80% of the maximum reaction rate produced no inhibition of enzyme activity. Exposure of enzyme preparations to stibine gas at concentrations sufficient to cause denaturation of red cell haemogloblin caused no measurable inhibition of esterase activity. 3. We conclude that stibine gas or soluble antimony compounds are not capable of inhibiting
cholinesterase
activity at toxicologically relevant concentrations.
...
PMID:Lack of inhibition of human plasma cholinesterase and red cell acetylcholinesterase by antimony compounds including stibine. 958 81